Kenji Kuwaki

Kenji Kuwaki

Auto-generated profile, based on publicly available information

Kenji Kuwaki

Department of Cardiovascular Surgery, Juntendo University, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2014 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
YYYasushi Yamasaki
Yasushi Yamasaki
Kazuhiro NousoKazuhiro Nouso
Kazuhiro Nouso
KMKoji Miyahara
Koji Miyahara
NWNozomu Wada
Nozomu Wada
CDChihiro Dohi
Chihiro Dohi
KYKazuhide Yamamoto
Kazuhide Yamamoto
Background and Aims: Serum glycans have been reported to be promising diagnostic markers for many inflammatory diseases and cancers. The aims of this study were to investigate whole glycan expression in patients with non‐alcoholic fatty liver diseases and to evaluate the potential use of glycan profiles as new clinical biomarkers to distinguish non‐alcoholic steatohepatitis (NASH) from simple steatosis (SS).Methods: We collected sera from 42 histologically proven NASH and 15 SS patients prior to treatment. Serum glycan profiles were measured by comprehensive, quantitative, high‐throughput glycome analysis, and diagnostic values of serum glycans for NASH prediction were examined.Results: Among the 41 serum glycans examined, the expression levels of 8 glycans in NASH were significantly higher than those of SS. Out of these eight glycans, three glycans (m/z 1955, 2032, and 2584) showed high areas under the receiver operating characteristic curve (0.833, 0.863, and 0.866, respectively) for distinguishing NASH from SS. In multivariate analyses with clinical parameters and serum glycans, these three glycans were significant predictive factors for distinguishing NASH from SS. The odds ratio of m/z 1955, 2032, and 2584 were 48.5, 6.46, and 11.8, respectively. These glycans also correlated significantly with lobular inflammation, ballooning, and fibrosis, but not with steatosis.Conclusion: We clearly demonstrated whole‐serum glycan profiles in NASH patients, and the feasibility of serum glycans (m/z 1955, 2032, and 2584) as new noninvasive biomarkers for distinguishing NASH from SS.

1 August 2016 in Journal of Cardiology
Verified
Journal Article
Closed access
HYHironobu Yamaoka
Hironobu Yamaoka
KKKenji Kuwaki
Kenji Kuwaki
HIHirotaka Inaba
Hirotaka Inaba
TYTaira Yamamoto
Taira Yamamoto
TKTomoko S. Kato
Tomoko S. Kato
AAAtsushi Amano
Atsushi Amano

1 July 2015 in The American Journal of Cardiology
Verified
Journal Article
Open access
YSYuichiro Sato
Yuichiro Sato
TKTomoko S. Kato
Tomoko S. Kato
AOAtsumi Oishi
Atsumi Oishi
TYTaira Yamamoto
Taira Yamamoto
KKKenji Kuwaki
Kenji Kuwaki
AAAtsushi Amano
Atsushi Amano
Renal dysfunction is a major adverse event after cardiovascular surgery. Therefore, the preoperative prediction of which patients will require renal replacement therapy (RRT) after cardiac surgery is an important issue. In the present study, 1,822 consecutive patients who underwent cardiovascular surgery from 2008 and 2013 at a single institution were reviewed. Patients who were already receiving long-term hemodialysis before surgery (n = 134) were excluded. The remaining 1,688 patients were separated into 2 groups: those requiring postoperative RRT and those without RRT requirement. A total of 128 patients (7.6%) required RRT. Patients requiring RRT had greater perioperative blood loss, longer intubation time, and longer hospital stays (p <0.0001 for all). Multivariate analysis revealed that cardiopulmonary bypass use, preoperative body surface area, the left ventricular ejection fraction, serum albumin, and creatinine were independent risk factors for postoperative RRT (odds ratios 2.435, 0.204, 0.976, 0.556, and 5.394, 95% confidence intervals 1.471 to 4.140, 0.054 to 0.841, 0.962 to 1.025, 0.363 to 0.860, and 3.671 to 8.223, respectively, p <0.05 for all). A subgroup of patients with relatively preserved renal function before surgery (creatinine <1.12 mg/dl, a cut-off value for RRT requirement obtained from receiver-operating characteristic curve analysis [area under the curve 0.74748, sensitivity 60.2%, specificity 85.0%]) showed that preoperative serum albumin concentration was most significantly associated with postoperative RRT requirement (odds ratio 0.048, 95% confidence interval 0.023 to 0.095, p <0.0001). In conclusion, cardiopulmonary bypass use, preoperative renal impairment as reflected by elevated creatinine level, small body size, a low left ventricular ejection fraction, and hypoalbuminemia were associated with a requirement for postoperative RRT. In patients with preserved renal function, hypoalbuminemia was most significantly related to requirement for RRT.

1 March 2012 in Journal of Cardiology
Verified
Journal Article
Closed access
SDShizuyuki Dohi
Shizuyuki Dohi
KKKan Kajimoto
Kan Kajimoto
KMKatsumi Miyauchi
Katsumi Miyauchi
TYTaira Yamamoto
Taira Yamamoto
KTKeiichi Tambara
Keiichi Tambara
AAAtsushi Amano
Atsushi Amano

14 February 2012 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
KKKenji Kuwaki
Kenji Kuwaki
AAAtsushi Amano
Atsushi Amano
HIHirotaka Inaba
Hirotaka Inaba
TYTaira Yamamoto
Taira Yamamoto
TMTakeshi Matsumura
Takeshi Matsumura
SMSatoshi Matsushita
Satoshi Matsushita
Background: The purpose of this study was to evaluate clinical risk factors and assess the impact of the Society of Thoracic Surgeons (STS) scores on outcomes after contemporary aortic valve replacement (AVR) for aortic stenosis (AS). Methods: We retrospectively analyzed the data from 209 consecutive patients with AS (mean 69 ± 9 years) who underwent AVR. The outcomes measured included operative mortality, postoperative complications, postoperative prolonged length of stay (PLOS), discharge to nonhome location, and mid‐term mortality. Results: Operative mortality was 3.8%, and five‐year survival was 88.6 ± 2.8%. Multivariable analysis revealed preoperative New York Heart Association (NYHA) class as a significant predictor of both operative mortality (p = 0.03; odds ratio [OR]: 8.5) and mid‐term mortality (p = 0.02; OR: 10.5). NYHA class also emerged as an independent predictor for postoperative complications (p = 0.002; OR: 5.8) and PLOS (p = 0.01; OR: 2.5). Other preoperative independent predictors included dialysis for PLOS (p = 0.04; OR: 2.9), age (p = 0.03; OR: 1.1), and left ventricular ejection fraction (EF; p = 0.03; OR: 0.9) for nonhome discharge, and EF for mid‐term mortality (p = 0.01; OR: 0.9). The mean STS‐PROM (predicted risk of mortality) was 4.6% ± 6.1%, and thus, the observed‐to‐expected (O/E) ratio of operative mortality in our series was 0.82. Conclusions: Advanced NYHA class, older age, dialysis, and lower EF are significant independent preoperative risk factors for early and mid‐term results of AVR for AS. Consideration of these predictors should be used to identify high‐risk patients requiring AVR for AS.

1 June 2015
Verified
Journal Article
Closed access
KKK Kuwaki
K Kuwaki
HIH Inaba
H Inaba
TYT Yamamoto
T Yamamoto
SDS Dohi
S Dohi
TMT Matsumura
T Matsumura
AAA Amano
A Amano